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The burden of cerebrovascular disease is increasing with stroke being the third leading cause of disability-adjusted 
life-years, accounting for 6.24 million deaths annually world-
wide.1,2 Around 90% of stroke risk is preventable and attrib-
utable to modifiable risk factors (RFs) including poor diet.3 
Conformity to a Mediterranean diet (MD) has been found to 
be beneficial for stroke prevention, although the results of 
previous studies have varied because of differences in study 
design, existing cardiovascular disease (CVD) risk within 
populations, and different methods of dietary assessment.4–6 
The beneficial effects of the MD are likely to be because 
of the overall effect or its constituent nutritional compo-
nents on lowering blood pressure, lipids, and inflammation 
and improving metabolic health.7 The MD forms part of the 
dietary recommendations for guidelines for the primary pre-
vention of stroke.8,9 However, only 2 prospective cohort stud-
ies have investigated the preventative effect of the MD on 
stroke in both men and women concurrently, despite recent 
guidelines suggesting that stroke prevention strategies should 
differ in men and women.10 This is because CVD risk profiles 
are sex specific, for example, women with diabetes mellitus 
experience a higher risk of stroke than men.10,11 Sex-specific 
research concerning the MD and risk of stroke has also been 
recommended because of the lack of studies with sufficiently 
robust outcome data.11
Although understanding the effect of the MD stroke risk 
is important for population prevention, previous studies have 
only investigated the effects of the MD either in populations 
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with high risk of CVD or without stratification for CVD risk 
across whole populations.5 We are unaware of previous stud-
ies investigating the associations between the MD in those 
with low and high risk for CVD and the MD.
Key components of a traditional MD include olive oil as 
the main source of fat, high intakes of fish, fruit, vegetables, 
nuts, and legumes, and low meat and dairy consumption with 
moderate alcohol consumption.12 The CVD preventive effect 
of MD is conferred by the nutrient and bioactive compound 
contributions from the foods within this pattern. However, al-
though the traditional MD is well established, the foods that 
contribute to it vary between Mediterranean and non-Medi-
terranean countries,13 resulting in different nutrient profiles 
for this dietary pattern. Moreover, food habits differ region-
ally even within Europe.14 This may impact on the median cut 
points of food and nutrient components that are used to form 
Mediterranean diet scores (MDSs) used in research and, there-
fore, the comparability between studies.
To our knowledge, although there have been studies that have 
examined the effect of an association between MD and incident 
stroke risk,4 only one previous study in the United Kingdom 
used food frequency questionnaire (FFQ) method to estimate 
food intake.15 Also, one small prospective cohort study (n=1849) 
previously used a 7-day diet diary (7DD) method16 despite this 
approach being considered more precise than FFQs for estimat-
ing food and nutrient intakes.17 FFQs are known to provide differ-
ing estimates of food components in comparison to food diaries, 
thus potentially distorting population median intake estimates of 
foods. For example, intakes of vegetables are ≈100 g/d higher 
when derived from FFQs compared with food diaries.18
The primary aims of our study were to examine whether 
greater adherence to MD was associated with reduced risk of 
incident stroke in a prospective cohort study of middle and 
older aged people. Given the previous research, our aims were 
first to understand whether the associations with the MD dif-
fered between men and women, second to understand these 
associations according to categories of CVD risk, and finally 
to understand whether the individual nutritional components 
of the MD were associated with risk of stroke.
Methods
Data will be available on request from the corresponding author, 
subject to approval by the European Prospective Investigations into 
Cancer and Nutrition (EPIC) Norfolk steering committee.
The current prospective cohort study includes 23 232 volun-
tary participants from a population-based cohort of 25 639 men and 
women from EPIC-Norfolk, the UK arm of the multicenter European 
Prospective Investigation into Cancer study (Figure I in the online-only 
Data Supplement). The EPIC-Norfolk study design and the character-
istics of the cohort have been described fully elsewhere.19 Briefly, all 
people aged between 40 and 79 years registered with 35 collaborat-
ing general practice surgeries in the Norfolk area were invited to the 
study by mail between 1993 and 1997. Participants who consented to 
the study completed a Health and Lifestyle Questionnaire and subse-
quently attended a health examination. The cohort is representative 
of a UK population, although current smoking levels were marginally 
lower than that reported in other UK surveys.19
Baseline Measurements
At baseline, participants were asked to complete 7DDs for all foods 
and drinks consumed.20 Full details on 7DD methodology in addition 
to the collection of health and lifestyle information and anthropo-
metric and biological measurements are available in the online-only 
Data Supplement. For the current analyses, we defined the MD using 
the modified MDS, frequently described as a traditional MD.13 In cal-
culating this score, one point is given for intakes of each protective 
item in the score at or above the sex-specific median for the study 
population, and zero is given for amounts below the sex-specific me-
dian. Protective items are fruit and nuts, vegetables, legumes, cere-
als (including bread and potatoes), fish, and a higher unsaturated 
fat:saturated fat ratio. For dairy and meat and eggs, intakes at or above 
the sex-specific median intake received 0 point; for intakes below the 
sex-specific median, 1 point was given. Women received 1 point for 
intakes of alcohol between 5 and 25 g/d (4.4–21.9 U/wk) and men 
who drank between 10 and 50 g/d (8.8–43.7 U/wk) alcohol received 
1 point; otherwise, men and women were given 0 points for other 
amounts of alcohol. Thus, a range of scores between 0 and 9 was 
possible.
Outcome Ascertainment
Linkage with hospital records and death certificate information de-
termined nonfatal and fatal stroke incidence. Stroke outcome data 
were available for almost 100% of the participants apart from a few 
individuals who died abroad (notified by relatives) and for whom 
we do not have a cause of death. These participants represent 1.4% 
of deaths within the cohort. International Classification of Disease 
codes ICD-9 430–448/ICD-10, I60-69 were classed as stroke. In 
the United Kingdom, all individuals have a unique National Health 
Service ID number, and the National Health Service is used by the 
whole population. This investigation includes incident strokes during 
follow-up (FU) until March 31, 2015. This outcome ascertainment 
method has been validated for stroke in EPIC showing high sensi-
tivity and specificity.21
Ethics
All participants gave written informed consent to the study. Norfolk 
District Health Authority Ethics Committee gave ethical approval.
Statistical Analysis
Statistical analyses were performed using Stata version 11 (StataCorp. 
2009. Stata Statistical Software: Release 14. StataCorp LP, College 
Station, TX).
We compared the baseline characteristics and unadjusted dietary 
intakes of men and women at baseline using 2 sample t tests with 
equal variance for continuous data or χ2 tests for categorical data. 
We also compared the baseline characteristics across sex-specific 
quartiles of MDS using ANOVA for continuous data or χ2 tests for 
categorical data.
Hazard ratios (HRs) and 95% CIs were determined for incident 
stroke risk in relation to quartiles of the MDS using Cox regression. 
For these analyses, we report the HRs, stratified by sex, from unad-
justed and 3 adjusted models. Model 1: sex, age, body mass index, 
educational attainment, physical activity, smoking status, material 
deprivation using the Townsend Index, energy intake, and alcohol 
intake. Model 2: model 1+baseline serum total cholesterol, baseline 
myocardial infarction (MI) or diabetes mellitus, and family history of 
stroke or MI. Model 3: Model 2+systolic blood pressure, antihyper-
tensive use, and aspirin use for >3 months. We also used Cox regres-
sion to examine the HRs for incident stroke comparing participants 
with intakes above and below the median for individual components 
of the MDS, with covariates as model 3 above.
To investigate the effect of MD adherence in individuals with 
different existing cardiovascular risk profiles, we performed further 
stratified analysis. We calculated the 10-year cardiovascular risk of 
participants using the traditional Framingham risk score22 and strati-
fied participants into 2 groups: low risk (Framingham risk score below 
the median) and high risk (Framingham risk score above the median). 
HRs and 95% CIs were determined for incident stroke risk across quar-
tiles of the MDS within these groups using Cox regression. Models 
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were adjusted for sex, age, body mass index, educational attainment, 
physical activity, smoking status, material deprivation using Townsend 
deprivation index, energy intake, alcohol intake, baseline MI, and 
family history of stroke or MI. We also stratified these analyses by sex.
Results
Of the 23 232 individuals aged 40 to 77 years at baseline (mean: 
59.1±9.3 years), 54.5% were women. There were 2009 incident 
strokes (men n=961 and women n=1048) during FU (mean: 
17.0±4.6 years; 395 048 total person-years). At baseline, systolic 
and diastolic blood pressure was significantly higher in men 
than in women by 3.6 mm Hg (SE: 0.2) and 3.5 mm Hg (SE: 0.1; 
P<0.001 for both), respectively. Mean MDS was 4.4 (SD: 1.6) 
in men and 4.2 (SD: 1.6) in women (P<0.01; Table 1). There 
was a significant trend for lower prevalence of current smok-
ing and higher physical activity levels by increasing quartiles of 
MDS for both men and women. In women only, higher adher-
ence to the MDS was also associated with lower age (P<0.01), 
body mass index (P<0.01), use of antihypertensive medication 
(P<0.01) and deprivation (P=0.03), and higher education levels 
(P<0.01; Table II in the online-only Data Supplement).
In multivariable analysis (Table 2), in the whole study 
population, there was a significant inverse trend for reduced 
stroke risk across increasing quartiles of the MDS (quartile 
4 versus quartile 1 HR, 0.83; 95% CI, 0.74–0.94; P-trend 
<0.01). After stratification by sex, these associations were 
only apparent in women (quartile 4 versus quartile 1 HR, 0.78; 
95% CI, 0.65–0.93; P-trend <0.01). Additionally, moderate 
MDS (quartile 3 versus quartile 1) was associated with a 20% 
significant stroke risk reduction in women (HR, 0.80; 95% 
CI, 0.67–0.95; P<0.05) but not in men. Sensitivity analysis 
with additional adjustment for hormone replacement therapy 
and menopausal status in women did not markedly change the 
results (data not shown).
As shown in Table 3, we found higher adherence to the 
MDS to be associated with reduced stroke risk in those partici-
pants at high cardiovascular risk (Framingham risk score above 
the cohort-specific median). Participants with highest adher-
ence to the MDS had a 13% reduced risk of stroke compared 
with those in the lowest MDS quartile (quartile 4 versus quar-
tile 1 HR, 0.87; 95% CI, 0.76–0.99; P-trend =0.04). No sig-
nificant associations were observed in the subgroup with low 
cardiovascular risk (quartile 4 versus quartile 1 HR, 0.77; 95% 
CI, 0.58–1.02; P-trend =0.09). After stratification by sex, it 
was apparent that the associations found in the high-risk group 
were driven by the findings in women. There was a reduction 
of 20% in the women (quartile 4 versus quartile 1 HR, 0.80; 
95% CI, 0.65–0.97; P-trend =0.02). However, the associations 
in the low-risk groups were not significant in either sex.
Analysis of the individual components of the MDS high-
lighted that the reduction in stroke risk seemed to be driven by 
the vegetable (HR, 0.87; 95% CI, 0.80–0.96) and alcohol (HR, 
0.90; 95% CI, 0.82–0.99) components of the score (Table III 
in the online-only Data Supplement).
Discussion
Our study found that greater adherence to the MD was as-
sociated with lower risk of stroke in a UK white population. 
We found these significant beneficial associations in the whole 
population with an HR 0.83 (95% CI, 0.74–0.94) between 
higher and lower adherence to the MD (quartile 4 versus quar-
tile 1). These associations were also significant in women 
(HR, 0.78; 95% CI, 0.65–0.93), and although the HR was 
lower in men (HR, 0.94; 95% CI, 0.79–1.12), the associations 
Table 1. Baseline Characteristics in 23 232 Men and Women Aged 40 to 77 
Years in the EPIC-Norfolk Cohort
Characteristic
Men Women
P Valuen=10 564 n=12 668
Age, yr 59.5 (9.3) 58.8 (9.3) <0.01
BMI, kg/m2 26.4 (3.2) 26.1 (4.3) <0.01
Reported DM, n (%) 318 (3.0) 179 (1.4) <0.01
Reported MI, n (%) 543 (5.1) 156 (1.2) <0.01
Family history stroke, n (%) 2427 (23.0) 3190 (25.2) <0.01
Family history MI, n (%) 3770 (35.7) 4713 (37.2) 0.02
Family history DM, n (%) 1291 (12.2) 1712 (13.5) 0.01
Systolic blood pressure, mm Hg 137 (17.5) 134 (18.8) <0.01
Diastolic blood pressure, mm Hg 84.3 (11.0) 80.8 (11.0) <0.01
Antihypertensive use, n (%) 1889 (17.9) 2335 (18.4) 0.28
Aspirin use, n (%) 1226 (11.6) 846 (6.7) <0.01
Total cholesterol, mmol/L 6.04 (1.1) 6.30 (1.2) <0.01
Framingham risk score* 0.24 (0.2) 0.12 (0.1) <0.01
Smoking, n (%)   <0.01
  Current smoker 1323 (12.5) 1521 (12.0)  
  Former smoker 5727 (54.2) 4029 (31.8)  
  Never 3514 (33.3) 7118 (56.2)
Physical activity, n (%)   <0.01
  Inactive 3195 (30.2) 3760 (29.7)  
  Moderately inactive 2588 (24.5) 4079 (32.2)  
  Moderately active 2456 (23.3) 2865 (22.6)  
  Active 2325 (22.0) 1964 (15.5)
Education, n (%)   <0.01
  No qualifications 3194 (30.2) 5301 (41.9)  
  O-level or equivalent 914 (8.7) 1465 (11.6)  
  A-level or equivalent 4823 (45.7) 4520 (35.7)  
  Degree or equivalent 1633 (15.5) 1382 (10.9)
TDI, n (%)   0.19
  T1 most deprived 3385 (32.0) 804 (33.2)
  T2 3617 (34.2) 827 (33.7)  
  T3 least deprived 3562 (33.7) 791 (33.1)
Incident strokes 961 (9.1) 1048 (8.3) 0.03
Values are represented as mean (SD) for continuous variables and n (%) for 
categorical variables. P value for the difference between males and females 
calculated using t test for continuous variables and χ2 for categorical variables. 
DM indicates diabetes mellitus; MI, myocardial infarction; and TDI, Townsend 
Deprivation Index.
*Framingham risk score calculated for n=22 465 participants with 
complete data.
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were not significant. We also found that risk of stroke differed 
by risk of CVD, classified by the Framingham risk score, as 
well as by the MD in the whole population (quartile 4 versus 
quartile 1 HR, 0.87; 95% CI, 0.76–0.99; P-trend =0.04) and 
in women (quartile 4 versus quartile 1 HR, 0.80; 95% CI, 
0.65–0.97; P-trend =0.02). To our knowledge, our study is the 
first to investigate and find differences in risk of stroke, not 
only according to the MD but also in those with low and high 
risk for CVD, and in men and women. Although our findings 
of a protective effect of the MD on risk of stroke were driven 
by women, they have implications for the general public and 
clinicians for the prevention of stroke.
We observed few significant associations with individual 
MD components, indicating that the effects of the MD may be 
attributable to the synergistic or additive effects of the indi-
vidual foods or nutrients within the MD12 and that the overall 
MD pattern was most important in relation to stroke risk.
Although previous systematic reviews and meta-analyses 
of RCTs and observational studies have shown significant in-
verse associations in relation to MD adherence and risk of 
incident stroke, with studies finding a relative risk of 0.66 
(95% CI, 0.48–0.92) and 0.73 (95% CI, 0.59–0.91), only 2 
observational studies investigated men and women separately 
in the same cohort.5,6,23,24 It is important to understand sex dif-
ferences in exposure to the MD because women have unique 
stroke RFs,11 which include postmenopausal hormone use, 
hormone status changes, pregnancy, preeclampsia, gestational 
diabetes mellitus, and oral contraceptive use. The prevalence 
of other RFs differs between men and women with hyperten-
sion, diabetes mellitus, atrial fibrillation, and migraine with 
aura11 being more prevalent in women.
Of the 2 other studies investigating sex differences 
in associations of stroke with the MD, one observational 
study in Hong Kong Chinese showed a significant inverse 
association with higher adherence to MD in men but not 
in women,23 whereas the other, in Greece, found reductions 
in incident stroke24 in women, only. It is not clear why we 
found differences in the associations between the MD and 
risk of stroke in men and women. However, we postulate 
that the components of the MD may influence the risk of 
Table 2. Associations Between Baseline MDS and Incident Stroke Risk in 23 232 Men and Women, Aged 40 to 77 Years in the EPIC-
Norfolk Cohort
 Quartile 1 Quartile 2 Quartile 3 Quartile 4 P-Trend
MDS 0–3 4 5 6–9  
All
  n 7324 5375 5165 5368 …
  Stroke events, n (%) 695 (9.5) 468 (8.7) 435 (8.4) 411 (7.7) …
  Unadjusted 1.00 (ref) 0.90 (0.80–1.01) 0.91 (0.80–1.02) 0.85 (0.75–0.96)* 0.01
  Model 1 1.00 (ref) 0.91 (0.81–1.02) 0.90 (0.80–1.02) 0.86 (0.76–0.97)* 0.02
  Model 2 1.00 (ref) 0.91 (0.81–1.02) 0.90 (0.80–1.01) 0.84 (0.74–0.95)* <0.01
  Model 3 1.00 (ref) 0.91 (0.81–1.02) 0.90 (0.80–1.01) 0.83 (0.74–0.94)* <0.01
Men
  n 3177 2402 2391 2594 …
  Stroke events, n (%) 303 (9.5) 201 (8.4) 219 (9.2) 238 (9.2) …
  Unadjusted 1.00 (ref) 0.84 (0.70–1.01) 0.89 (0.75–1.06) 0.95 (0.80–1.13) 0.61
  Model 1 1.00 (ref) 0.86 (0.72–1.03) 0.91 (0.76–1.08) 0.98 (0.82–1.16) 0.81
  Model 2 1.00 (ref) 0.86 (0.72–1.03) 0.89 (0.74–1.05) 0.95 (0.80–1.13) 0.57
  Model 3 1.00 (ref) 0.86 (0.72–1.03) 0.90 (0.75–1.07) 0.94 (0.79–1.12) 0.55
Women
  n 4184 2983 2717 2784 …
  Stroke events, n (%) 406 (9.7) 256 (8.6) 196 (7.2) 190 (6.8) …
  Unadjusted 1.00 (ref) 0.88 (0.75–1.03) 0.79 (0.67–0.94)* 0.78 (0.66–0.93)* <0.01
  Model 1 1.00 (ref) 0.89 (0.76–1.04) 0.81 (0.68–0.96)* 0.80 (0.67–0.95)* <0.01
  Model 2 1.00 (ref) 0.88 (0.75–1.03) 0.80 (0.68–0.95)* 0.79 (0.66–0.94)* <0.01
  Model 3 1.00 (ref) 0.87 (0.74–1.02) 0.80 (0.67–0.95)* 0.78 (0.65–0.93)* <0.01
Values are represented as unadjusted or adjusted hazard ratios (95% CI). P-trend proportional hazards regression. n (%) represents 
number and percentage of stroke events within each quartile. MDS indicates Mediterranean diet score; and MI, myocardial infarction.
*Significantly different to quartile 1 (P<0.05). Hazard ratios adjustment: model 1=sex, age, body mass index, educational 
attainment, physical activity, and smoking status; material deprivation using Townsend index, energy, and alcohol intake. Hazard 
ratios adjustment model 2=model 1+baseline serum total cholesterol, MI, or diabetes mellitus, and family history of stroke, or 
MI; Hazard ratios adjustment model 3=model 2+systolic blood pressure, antihypertensive medication use, and aspirin use for >3 mo.
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stroke in women more than in men. We are also aware that 
the different subtypes of stroke may differ in men between 
sexes and may lead to heterogeneity of response to the 
MDS.24 We were unable to test this hypothesis in our cohort 
because of low incidence. However, this deserves further 
study in the future.
One previous study in the United Kingdom found a 
nonsignificant inverse association (HR, 0.96; 95% CI = 
0.90–1.02) with greater MD adherence and incident stroke.15 
However, this study did not stratify by sex, the MD was 
based on FFQs, and average FU was 12.2 years. We build 
on their analyses by including sex stratified analyses, using 
7DDs with a longer FU period.
Study Strengths
The strengths of our study include the prospective de-
sign, the use of a comprehensive 7DD, robust outcome 
assessment method, with few individuals lost to FU, and, 
besides smoking status, the population is representative of 
the United Kingdom.19 Another of our study’s advantages 
include longer FU of 17 years than all except one study in 
women, only. In addition, using 7DD to measure dietary/
nutritional intake is more precise than FFQs, which may 
overestimate the important components of MD.17 We con-
trolled for and measured potential nondietary confounding 
factors that affect stroke risk, namely, directly measured 
BP and cholesterol at baseline. Also, we had sufficient 
power to detect an effect of adherence to the MD on in-
cident stroke in the population and in women when meas-
ured separately.
Limitations
Dietary assessment was based on one assessment at baseline, 
which does not exclude the possibility that dietary changes or 
Table 3. Associations Between Baseline MDS and Incident Stroke Risk in 22 465 Men and Women, Aged 40 to 77 Years in the EPIC-
Norfolk Cohort Stratified by Framingham Risk Score
 Quartile 1 Quartile 2 Quartile 3 Quartile 4 P-Trend
All: low cardiovascular risk     0.09
  n 3448 2575 2547 2662  
  Stroke events, n (%) 139 (4.0) 103 (4.0) 98 (3.9) 80 (3.0)  
  HR (95% CI) 1.00 (ref) 0.95 (0.74–1.23) 0.96 (0.74–1.24) 0.77 (0.58–1.02)  
All: high cardiovascular risk     0.04
n 3876 2800 2618 2706  
Stroke events, n (%) 556 (14.3) 365 (13.0) 337 (12.9) 331 (12.2)  
HR (95% CI) 1.00 (ref) 0.90 (0.79–1.03) 0.89 (0.78–1.02) 0.87 (0.76–0.99)  
Men: low cardiovascular risk     0.92
  n 1392 1138 1986 513  
  Stroke events, n (%) 55 (4.0) 34 (3.0) 76 (3.8) 20 (3.9)  
  HR (95% CI) 1.00 (ref) 0.77 (0.50–1.18) 0.97 (0.68–1.38) 0.91(0.55–1.53)  
Men: high cardiovascular risk     0.27
  n 1663 1267 1266 1339  
  Stroke events, n (%) 240 (14.4) 172 (13.6) 177 (14.0) 187 (14.0)  
  HR (95% CI) 1.00 (ref) 0.90 (0.74–1.09) 0.90 (0.74–1.10) 0.89 (0.74–1.09)  
Women: low cardiovascular risk     0.21
  n 1982 1411 1362 1448  
  Stroke events, n (%) 63 (3.2) 46 (3.3) 33 (2.4) 39 (2.7)  
  HR (95% CI) 1.00 (ref) 0.98 (0.67–1.44) 0.73 (0.48–1.11) 0.84 (0.56–1.25)  
Women: high cardiovascular risk     0.02
  n 2287 1559 1352 1267  
  Stroke events, n (%) 337 (14.7) 216 (13.9) 170 (12.6) 144 (11.4)  
  HR (95% CI) 1.00 (ref) 0.92 (0.78–1.10) 0.87 (0.72–1.05) 0.80 (0.65–0.97)  
Values are represented as adjusted HRs (95% CI). P-trend represents proportional hazards regression. n (%) represents number 
and percentage of stroke events within each quartile. Model adjustment: sex, age, BMI, educational attainment, physical activity, 
smoking status, material deprivation using Townsend index, energy and alcohol intakes, baseline MI, and family history of stroke or 
MI. Low cardiovascular risk represents below median Framingham risk score, and high cardiovascular risk represents at or above 
median Framingham risk score. Mean±SD, median, and range for Framingham Risk Score within each category were as follows: low 
cardiovascular risk = 0.07±0.03, 0.07, 0.01–0.13; high cardiovascular risk = 0.28±0.13, 0.24, 0.13–0.97. BMI indicates body mass 
index; CI, confidence interval; HR, hazard ratio; MDS, Mediterranean diet score; and MI, myocardial infarction.
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other treatments may occur subsequently, which would alter 
incident stroke risk. In addition, we did not control for some 
stroke RFs, for example, atrial fibrillation. Nevertheless, we 
controlled for major stroke RFs such as previous MI, BP, and 
vascular diseases. The MDS uses relative rather than absolute 
values for MD components. This limits comparison with other 
studies using the same score, as median intakes may be dis-
tinct in different populations. Our population was predomi-
nantly white, and, therefore, our results may not apply to other 
ethnic groups.
Summary
Greater adherence to the MD was associated with lower risk 
of stroke in a UK white population, which was attributable to 
the overall MD pattern, not its individual components. For the 
first time in the literature, we also investigated the potential 
benefits of the MD in people at low and high risk of CVD, in 
men and in women. Although the findings in our study were 
driven by the associations in women, they have implications 
for the general public and clinicians for prevention of stroke.
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